The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Christopher J. Sweeney

Department of Medicine

Indiana University

535 Barnhill Drive

Indianapolis

USA

[email]@iupui.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Medicine, Indiana University, 535 Barnhill Drive, Indianapolis, USA. 2003 - 2010
  • Indiana University, Indianapolis, Indiana 46202, USA. 2003 - 2004

References

  1. A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment. Sweeney, C.J., Takimoto, C., Wood, L., Porter, J.M., Tracewell, W.G., Darwish, M., D'Andrea, D.M., Remick, S.C. Cancer Chemother. Pharmacol. (2010) [Pubmed]
  2. The case for systemic therapy alone for prostate cancer. Sweeney, C. J. Urol. (2006) [Pubmed]
  3. A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer. Sweeney, C., Liu, G., Yiannoutsos, C., Kolesar, J., Horvath, D., Staab, M.J., Fife, K., Armstrong, V., Treston, A., Sidor, C., Wilding, G. Clin. Cancer Res. (2005) [Pubmed]
  4. Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate. Sweeney, C., Li, L., Shanmugam, R., Bhat-Nakshatri, P., Jayaprakasan, V., Baldridge, L.A., Gardner, T., Smith, M., Nakshatri, H., Cheng, L. Clin. Cancer Res. (2004) [Pubmed]
  5. Resistance in the anti-angiogenic era: nay-saying or a word of caution?. Sweeney, C.J., Miller, K.D., Sledge, G.W. Trends. Mol. Med (2003) [Pubmed]
  6. Why cyclooxygenase-2 inhibition plus chemotherapy?. Sweeney, C.J. Am. J. Clin. Oncol. (2003) [Pubmed]
 
WikiGenes - Universities